Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Valion Bio (TIVC) Other Non Operating Income (2021 - 2022)

Valion Bio has reported Other Non Operating Income over the past 2 years, most recently at -$1000.0 for Q3 2022.

  • For Q3 2022, Other Non Operating Income fell 101.25% year-over-year to -$1000.0; the TTM value through Sep 2022 reached $462000.0, changed N/A, while the annual FY2021 figure was $436000.0, N/A changed from the prior year.
  • Other Non Operating Income for Q3 2022 was -$1000.0 at Valion Bio, down from $355000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $355000.0 in Q4 2021 and troughed at -$27000.0 in Q1 2021.